cytosine has been researched along with eye in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, AH; Haft, DA; Loran, MR; Miller, MH; Walsh, A | 1 |
| Owen, RJ; Snell, JJ | 1 |
| Fristrom, D | 1 |
| Field, HJ; Gilliam, SE | 1 |
| Cundy, KC; Hitchcock, MJ; Lee, WA; Lynch, G; Shaw, JP | 1 |
| de Oliveira, CB; LaBree, L; McDonnell, PJ; Stevenson, D; Trousdale, MD | 1 |
| Cheng, B | 1 |
| Feinberg, J | 1 |
| Gordon, YJ; Romanowski, EG; Yates, KA | 1 |
| Beadle, JR; Cheng, L; Freeman, WR; Hoh, C; Hostetler, KY; Tammewar, A | 1 |
| Chavala, S; Miller, MB; Moss, HB; Say, E | 1 |
| Bagui, M; Barot, M; Gokulgandhi, MR; Mitra, AK; Pal, D | 1 |
1 trial(s) available for cytosine and eye
| Article | Year |
|---|---|
Update on treatment of CMV retinitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Eye; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Randomized Controlled Trials as Topic | 1995 |
11 other study(ies) available for cytosine and eye
| Article | Year |
|---|---|
Ocular penetration of 5-fluorocytosine.
Topics: Administration, Oral; Administration, Topical; Animals; Aqueous Humor; Cytosine; Eye; Flucytosine; Kinetics; Rabbits; Vitreous Body | 1978 |
Comparison of group IIf with Flavobacterium and Moraxella.
Topics: Bacteria; Bacteriological Techniques; Blood; Cytosine; DNA, Bacterial; Eye; Female; Flavobacterium; Guanine; Humans; Male; Moraxella; Pigments, Biological; Urethra; Vagina | 1973 |
Chemical modification of cell death in the Bar eye of Drosophila.
Topics: Acetamides; Animals; Cell Differentiation; Cytosine; Drosophila melanogaster; Eye; Female; Larva; Male; Morphogenesis; Mutation | 1972 |
The effect of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine (HPMPC) on bovine herpesvirus-1 (BHV-1) infection and reactivation in cattle.
Topics: Animals; Antiviral Agents; Body Temperature; Cattle; Cidofovir; Cytosine; Dexamethasone; Drug Tolerance; Evaluation Studies as Topic; Eye; Herpesvirus 1, Bovine; Infectious Bovine Rhinotracheitis; Male; Nasal Cavity; Organophosphonates; Organophosphorus Compounds; Virus Replication | 1993 |
Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Eye; Half-Life; Humans; Injections; Kidney; Male; Organophosphonates; Organophosphorus Compounds; Rabbits; Retina; Tissue Distribution; Vitreous Body | 1996 |
Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antibodies, Viral; Cidofovir; Cytosine; Disease Models, Animal; Drug Evaluation; Enzyme-Linked Immunosorbent Assay; Eye; Female; Humans; Organophosphonates; Organophosphorus Compounds; Rabbits; Tears; Tumor Cells, Cultured | 1996 |
Advances in the treatment of CMV.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Eye; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Quality of Life | 1995 |
Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Conjunctivitis, Viral; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Eye; Female; Organophosphonates; Organophosphorus Compounds; Rabbits; Virus Cultivation; Virus Replication | 2001 |
Intraocular pharmacokinetics of a crystalline lipid prodrug, octadecyloxyethyl-cyclic-cidofovir, for cytomegalovirus retinitis.
Topics: Animals; Antiviral Agents; Autoradiography; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Eye; Intravitreal Injections; Organophosphonates; Prodrugs; Rabbits | 2011 |
Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA, Viral; Drug Resistance, Viral; Eye; Female; Foscarnet; Ganciclovir; Humans; Organophosphonates; Plasma; Sequence Analysis, DNA | 2012 |
Transporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.
Topics: Animals; Antiviral Agents; Biological Transport; Biotinylation; Biotransformation; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Dogs; Eye; Lipid Metabolism; Lipids; Male; Octanols; Organophosphonates; Prodrugs; Rabbits; Solubility; Symporters; Technology, Pharmaceutical; Water | 2012 |